Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease

WS Weintraub, B Stein, A Kosinski, JS Douglas… - Journal of the American …, 1998 - jacc.org
Objectives. This study sought to compare the outcome of percutaneous transluminal
coronary angioplasty (PTCA)(n= 834) and coronary artery bypass graft surgery (CABG)(n …

Myocardial infarction and cardiac mortality in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial

BR Chaitman, AD Rosen, DO Williams, MG Bourassa… - Circulation, 1997 - Am Heart Assoc
Background Cardiac mortality and myocardial infarction (MI) rates are used to evaluate the
efficacy of coronary artery bypass grafting (CABG) and percutaneous transluminal coronary …

Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Bypass Angioplasty Revascularization …

KM Detre, P Guo, R Holubkov, RM Califf, G Sopko… - Circulation, 1999 - Am Heart Assoc
Background—Patients with treated diabetes in the randomized-trial segment of the Bypass
Angioplasty Revascularization Investigation (BARI) who were randomized to initial …

[HTML][HTML] The effect of previous coronary artery stenting on short-and intermediate-term outcome after surgical revascularization in patients with diabetes mellitus

HA Tran, SD Barnett, SL Hunt, A Chon, N Ad - The Journal of Thoracic and …, 2009 - Elsevier
OBJECTIVES: Percutaneous intervention for coronary revascularization is associated with
an increased risk of repeat revascularization, especially in patients with diabetes mellitus. In …

Short-and long-term results after multivessel stenting in diabetic patients

JW Moses, R Mehran, GD Dangas, Y Kobayashi… - Journal of the American …, 2004 - jacc.org
Objectives: The present study evaluated clinical outcomes in diabetic patients after
multivessel stenting. Background: Multivessel angioplasty studies have reported decreased …

The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic …

S Bansilal, ME Farkouh, W Hueb, M Ogdie… - American heart …, 2012 - Elsevier
BACKGROUND: The optimal revascularization strategy for diabetic patients with multivessel
coronary artery disease (MVD) remains uncertain for lack of an adequately powered …

Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials)

TT Lee, L Feinberg, DS Baim, DR Holmes… - The American journal of …, 2006 - Elsevier
Diabetes mellitus (DM) increases the risk of clinically driven, repeat revascularization of the
stented lesion in the first year after coronary stenting. The effect of DM on the risk of repeat …

Stroke rates following surgical versus percutaneous coronary revascularization

SJ Head, M Milojevic, J Daemen, JM Ahn… - Journal of the American …, 2018 - jacc.org
Background: Coronary artery bypass grafting (CABG) and percutaneous coronary
intervention (PCI) are used for coronary revascularization in patients with multivessel and …

A 3-year clinical outcome after percutaneous coronary intervention using sirolimus-eluting stent and off-pump coronary artery bypass grafting for the treatment of …

K Yamagata, Y Kataoka, N Kokubu, Y Kasahara… - Circulation …, 2010 - jstage.jst.go.jp
Background: There are few data to compare the long-term efficacy of sirolimus-eluting stent
(SES) and off-pump coronary artery bypass grafting (OPCAB) for diabetic patients with …

Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients: 1-year results of the CARDia (Coronary …

A Kapur, RJ Hall, IS Malik, AC Qureshi, J Butts… - Journal of the American …, 2010 - jacc.org
Objectives: The purpose of this study was to compare the safety and efficacy of
percutaneous coronary intervention (PCI) with stenting against coronary artery bypass …